Rahul R. Jhaveri, M.D.

NPI 1710013396ActiveIndividual· Internal Medicine, Interventional Cardiology· Lancaster, PA

Internal Medicine, Interventional Cardiology (M.D.) in Lancaster, Pennsylvania, trained at New York University School of Medicine (class of 2012). In 2024 Medicare paid $178,890 for 4,622 patients, and Part D covered 162 of their prescriptions, 82% of them generic. Abbott Laboratories was the largest of 3 companies reporting payments in 2025, $1,998 in all, mostly travel and lodging.

Overview

NPI	1710013396
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Feb 26, 2007
Last updated in NPPES	Mar 14, 2025
Certified by provider	Mar 14, 2025

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Interventional Cardiology Primary	207RI0011X	MD453682	PA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Interventional Cardiology (PA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	4,622
Services billed	6,527 across 70 procedure codes
Paid by Medicare	$178,890

Part D prescriptions in 2024

Prescriptions (claims)	162 · 366 30-day fills
Patients	75
Total drug cost	$26,656
Generic share	82% of claims

Medicare sources and data years

Education and affiliations

Medical school	New York University School of Medicine
Graduation year	2012
Medicare specialty	Interventional Cardiology
Secondary specialties	Cardiovascular Disease (Cardiology)